Fabry disease in India: A multicenter study of the clinical and mutation spectrum in 54 patients

JIMD Reports
Sheela NampoothiriUma Ramaswami

Abstract

Fabry disease (FD) is a treatable X linked lysosomal storage disorder with a wide phenotypic spectrum. There is a scarcity of published data on the burden of FD in India. This study evaluates the clinical and molecular spectrum of Indian patients with FD. In this multicentric study involving 10 tertiary referral centers in India, we analyzed the clinical course and genotype of 54 patients from 37 families. Family screening identified 19 new patients (35%) from 12 index cases. Then, 33 GLA gene variants were identified in 49/54 (90.7%) which included 11 novel and 22 known pathogenic variants. Of the 54 patients in our cohort, 40 patients had "classical" and 10 patients had a "nonclassical" presentation. The symptoms and signs included kidney dysfunction in 38/54 (70.3%), neuropathic pain in 34/54 (62.9%), left ventricular hypertrophy in 22/49 (44.8%) and stroke in 5/54 (9.2%). Female heterozygotes were 10/54 (18.5%) of whom 2 were index cases. There was a significant delay in reaching the diagnosis of 11.7 years. Enzyme replacement therapy was initiated in 28/54 (51.8%) patients with significant improvement of neuropathic pain and gastrointestinal symptoms. This study highlights the clinical presentation and mutational spectrum ...Continue Reading

References

Oct 18, 2005·Journal of Medical Genetics·P B DeeganUNKNOWN European FOS Investigators
Jan 4, 2008·Journal of Genetic Counseling·Dawn A Laney, Paul M Fernhoff
Oct 23, 2008·Lancet·Yuri A Zarate, Robert J Hopkin
Oct 3, 2009·Journal of Medical Genetics·G E LinthorstC E M Hollak
Nov 26, 2010·Orphanet Journal of Rare Diseases·Dominique P Germain
Jun 20, 2012·Gene·Deborah ElsteinGheona Altarescu
Jun 28, 2012·European Heart Journal·Zaheer YousefFrank Weidemann
Mar 2, 2013·Current Pharmaceutical Design·Aris AnastasakisAlexandros Klavdios Steriotis
Jan 18, 2015·Journal of Medical Genetics·Bouwien E SmidBen J H M Poorthuis
Nov 8, 2015·Molecular Genetics and Metabolism·Robert J HopkinUNKNOWN Fabry Pediatric Expert Panel
Dec 17, 2016·Journal of the American Society of Nephrology : JASN·Maarten ArendsCarla E Hollak
Dec 19, 2017·Kidney & Blood Pressure Research·Luciana Senra de Souza SodréNatália Maria da Silva Fernandes
Mar 14, 2018·Molecular Genetics and Metabolism·Alberto OrtizWilliam R Wilcox
Apr 11, 2018·Orphanet Journal of Rare Diseases·Irene VieitezSaida Ortolano
Nov 22, 2019·Drug Design, Development and Therapy·Uma RamaswamiUNKNOWN FOS Study Group

❮ Previous
Next ❯

Citations

Jul 20, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jyotsna VermaI C Verma

❮ Previous
Next ❯

Methods Mentioned

BETA
enzymatic assay
biopsy
PCR

Software Mentioned

INCAP

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.